Neiratax (Thiamine Hydrochloride, Cyanocobalamin, Pyridoxine Hydrochloride, Lidocaine Hydrochloride)

The vitamin components serve as essential cofactors in metabolic pathways: thiamine supports carbohydrate metabolism, cyanocobalamin is vital for DNA synthesis and nerve health, and pyridoxine assists amino‑acid metabolism. Lidocaine blocks voltage‑gated sodium channels, preventing nerve depolarization and producing a reversible local anesthetic effect at the injection site.

The appropriate dose of Neiratax is determined by the prescribing healthcare professional based on the patient’s clinical condition, age, weight, and the specific indication. Dosage information is provided on the product label and should be followed exactly as directed by the prescriber.

Safety data for Neiratax in pregnancy and lactation are limited. It should be used only if the potential benefit justifies any potential risk to the fetus or infant. Healthcare providers should evaluate each case individually and discuss possible risks with the patient.

To place an order, submit an enquiry on the Neiratax product page at gnhindia.com, specifying the required quantity. GNH India works with hospitals, pharmacies, and procurement teams worldwide, verifies trade or institutional credentials, and then provides pricing, availability, shipping details (including cold‑chain if needed), and any required import documentation.

Neiratax uniquely combines three B‑vitamins with a local anesthetic in a single intramuscular formulation, offering both nutritional supplementation and immediate analgesia. Other vitamin‑B injectables typically contain only one or two vitamins and lack an anesthetic component, requiring separate pain‑management measures for procedures.

Neiratax should be stored at 2‑8 °C in a refrigerator, protected from light, and must not be frozen or shaken. Keep the vial in its original packaging until use and discard any solution that appears discolored or contains particles.

Neiratax is administered by a qualified healthcare professional via intramuscular injection. The injection site should be cleaned with an appropriate antiseptic, and the recommended volume is injected slowly to minimize discomfort and ensure proper absorption of both the vitamins and lidocaine.

Serious risks include severe allergic reactions such as anaphylaxis, cardiovascular instability (significant hypotension or arrhythmias), central nervous system toxicity (seizures, loss of consciousness), and rare dermatologic emergencies like Stevens‑Johnson syndrome. Immediate medical attention is required if any of these symptoms occur.

Neiratax is contraindicated in individuals with known hypersensitivity to any of its components, including lidocaine or the B‑vitamins. It should also be avoided in patients with severe cardiac conduction disorders, significant hepatic impairment, or those for whom the safety of the ingredients during pregnancy or lactation has not been established.